These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 4422494)
1. Immunity in the tumor-bearing host and its modification by serum factors. Baldwin RW; Embleton MJ; Price MR; Robins A Cancer; 1974 Oct; 34(4 Suppl):suppl:1452-60. PubMed ID: 4422494 [No Abstract] [Full Text] [Related]
2. Nutrition and tumor immunity: divergent effects of antitumor antibody. Bull DM Cancer Res; 1975 Nov; 35(11 Pt. 2):3317-9. PubMed ID: 1104143 [TBL] [Abstract][Full Text] [Related]
3. Lymphocyte mediated cytotoxicity to tumor antigens. Hellström I; Hellström KE Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238 [No Abstract] [Full Text] [Related]
4. Effects on tumor growth in vivo by manipulation of the tumor immune response. Sjögren HO Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816 [No Abstract] [Full Text] [Related]
5. Cellular and humoral immune interactions during neoplastic development. Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716 [No Abstract] [Full Text] [Related]
6. Humoral factors abrogating cell-mediated immunity in the tumor-bearing host. Baldwin RW; Robins RA Curr Top Microbiol Immunol; 1975; 72():21-53. PubMed ID: 767057 [No Abstract] [Full Text] [Related]
10. Significance of serum factors modifying cellular immune responses to growing tumours. Baldwin RW; Price MR; Robins RA Br J Cancer Suppl; 1973 Aug; 1():37-47. PubMed ID: 4374231 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-mediated immune responses in neoplasia. Pilch YH; Golub SH Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086 [No Abstract] [Full Text] [Related]
12. [Immunology and cancer]. Brunner KT Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090 [No Abstract] [Full Text] [Related]
13. Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals. Hellström I; Hellström KE; Kall MA; Nelson K; Pollack S Transplant Proc; 1976 Jun; 8(2):255-64. PubMed ID: 936286 [No Abstract] [Full Text] [Related]
14. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms. Hellström I; Hellström KE Cancer; 1974 Oct; 34(4 Suppl):suppl:1461-8. PubMed ID: 4417442 [No Abstract] [Full Text] [Related]
15. Tumour-associated antigens. Baldwin RW Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 May; 89(1):1-8. PubMed ID: 69367 [No Abstract] [Full Text] [Related]
16. Factors interfering with immunological rejection of tumours. Baldwin RW; Robins RA Br Med Bull; 1976 May; 32(2):118-23. PubMed ID: 782631 [No Abstract] [Full Text] [Related]
17. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status. Baldwin RW; Embleton MJ; Robins RA Int J Cancer; 1973 Jan; 11(1):1-10. PubMed ID: 4133609 [No Abstract] [Full Text] [Related]
18. Clinical aspects of cancer immunity. Moore GE Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116 [No Abstract] [Full Text] [Related]
19. Diminished in vitro toxic effect of phytohaemagglutinin for lymphocytes of rats bearing syngeneic tumours. Medzihradský J; Babusíková O; Koníková E Neoplasma; 1973; 20(4):353-61. PubMed ID: 4147074 [No Abstract] [Full Text] [Related]
20. In vitro-demonstration of cellular hypersensitivity to tumour antigens in man. Andersen V; Kjaer M; Bendixen G Ser Haematol; 1972; 5(5):3-21. PubMed ID: 4598039 [No Abstract] [Full Text] [Related] [Next] [New Search]